Glatiramer acetate versus interferon Beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients

By Castelli-Haley Jane  

Advances in Therapy, Vol. 25, Iss. 8, 2008-08 ,pp. : 830-830

Springer Publishing Company

Access to resources Recommend Favorite

Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 3, 2015-03 ,pp. : 425-435

John Wiley & Sons Inc

Access to resources Recommend Favorite

IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis

By  

International Archives of Allergy and Immunology, Vol. 165, Iss. 4, 2015-01 ,pp. : 244-246

Karger

Access to resources Recommend Favorite

Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis*

By Sheng Duh Mei   Dial Ellison   Choueiri Toni K.   Fournier Andree-Anne   Antras Lucia   Rodermund Douglas   Neary Maureen P.   Oh William K.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 2081-2090

Informa Healthcare

Access to resources Recommend Favorite

A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis

By Wu Eric Q.   Birnbaum Howard   Kang Yoon Jun   Parece Andrew   Mallett David   Taitel Haya   Evans Robert J.  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 495-500

Informa Healthcare

Access to resources Recommend Favorite